Nomura Asset Management’s Medpace MEDP Stock Holding History

Nomura Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,027	Closed	-$2.18M	–	1564
2021 Q4	$2.18M	Buy	+10,027	New	+$2.1M	0.01%	731

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Asset Management's MEDP Position: Q1 2022 in Review

Nomura Asset Management sold out of Medpace (MEDP) in Q1 2022, closing a stake of 10,027 shares — an estimated $2.18M sold.

Nomura Asset Management first reported a position in MEDP in Q4 2021 and held it in 1 quarter. The position peaked at $2.18M in Q4 2021. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

Nomura Asset Management reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
Nomura Asset Management sold 10,027 Medpace shares in Q1 2022, an estimated $2.18M.
Nomura Asset Management first reported a position in Medpace in Q4 2021 and held it in 1 quarter.
Nomura Asset Management's Medpace position peaked at $2.18M in Q4 2021.
349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Nomura Asset Management's 13F filing for Q1 2022, filed 13 May 2022.